Skip to main content

Table 1 Incidence of TLN in subgroups defined by ROC curve analysis of rVX, aVX, Dmax and Dmean

From: Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy

Variable

Range (median)

Group

No. of TLs

Incidence of TLN

χ 2

P value

rV10

6.8%–100%(37.86%)

≤42%

316

1.9%

53.360

0.000

>42%

185

22.2%

aV10

7.32–107.86 cc(29.00 cc)

≤38 cc

358

2.8%

  
  

>38 cc

143

25.9%

64.033

0.000

rV20

4.16%–100%(21.12%)

≤21%

272

0.7%

52.326

0.000

>21%

229

19.7%

aV20

2.93–107.86 cc(16.02 cc)

≤17 cc

294

0.7%

63.368

0.000

>17 cc

207

21.7%

rV30

1.80%–99.99%(12.67%)

≤20%

364

2.7%

  
  

>20%

137

27%

68.911

0.000

aV30

1.10–107.85 cc(9.39 cc)

≤15 cc

358

2.2%

  
  

>15 cc

143

27.3%

75.354

0.000

rV40

0.06%–99.52%(6.59%)

≤11%

363

2.5%

  
  

>11%

138

27.5%

73.846

0.000

aV40

0.04–107.34 cc(4.92 cc)

≤11 cc

409

2.7%

  
  

>11 cc

92

39.1%

117.321

0.000

rV50

0.00%–98.07%(2.49%)

≤5%

363

1.7%

  
  

>5%

138

29.7%

92.589

0.000

aV50

0.00–105.78 cc(1.92 cc)

≤4 cc

364

1.6%

  
  

>4 cc

137

29.9%

93.632

0.000

rV60

0.00%–92.58%(0.25%)

≤2%

422

4.0%

  
  

>2%

79

38.0%

90.200

0.000

aV60

0.00–99.86 cc(0.20 cc)

≤2 cc

430

4.0%

  
  

>2 cc

71

42.3%

105.150

0.000

rV66

0.00%–77.40%(0.00%)

≤0.1%

340

0.9%

  
  

>0.1%

161

27.3%

89.895

0.000

aV66

0.00–83.48 cc(0.00 cc)

≤0.2 cc

361

1.1%

  
  

>0.2 cc

139

30.2%

101.788

0.000

rV70

0.00%–50.65%(0.00%)

≤0.01%

351

1.7%

  
  

>0.01%

150

27.3%

81.166

0.000

aV70

0.00–54.64 cc(0.00 cc)

≤0.07 cc

380

2.4%

  
  

>0.07 cc

121

31.4%

91.021

0.000

Dmax

32.4–84.9 Gy(66.15 Gy)

≤68.85 Gy

321

0.6%

80.616

0.000

>68.85 Gy

180

25.0%

Dmean

3.9–35.7 Gy(11.70 Gy)

≤11.55 Gy

273

0.4%

57.347

0.000

  

>11.55 Gy

228

20.2%